3Naghavi M, Libby P, Falk E, et al. From vulnerableplaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part Ⅱ [J]. Circulation,2003, 108(15): 1772-8.
4Mayuml S, Toshihiko I, Junichi M, et al. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors [J]. Atherosclerosis, 2003,167( ):73-79.
5Kaski JC, Chester MR, Chen L, et al. Rapid angiograhic progression of coronary artery disease in patients with angina pectoris: the role of complex stenosis morphology[J]. Circulation, 1995, 92(8):2058-65.
6Rifai N, Ridker P. Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening [J]. Clin Chem, 2001, 47(1):28-30.
7Lawrence JB, Oxvig C, Overgaard MT, et al. The insulin-like growth factor (IGF) dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A [J]. Proc Natl Acad Sci USA, 1999, 96(6):3149-53.
8Bayes-Genis A, Conover CA, Overgaard MT, et al.Pregnancy associated plasma protein A as a marker of acute coronary syndromes [J]. N Engl J Med, 2001, 345(14): 1022-9.
9Khosravi J, Diamandi A, Krishna RG,et al. Pregnancy associated plasma protein-A: ultrasensitive immunoassay and determination in coronary heart disease [J]. Clin Bioc, 2002, 35(7):531-8.
10Beaudeux JL, Burc L, Imbert-Bismut F, et al. Serum plasma pregnancy-associated protein A-A potential marker of echogenic carotid atherosclerotic plaques in asymptomatic hyperlipidemic subjects at high cardiovascular risk [J]. Arterioscler Thromb Vasc Biol,2003, 23(1):e7-e10
